SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-003441
Filing Date
2022-11-14
Accepted
2022-11-14 17:28:16
Documents
92
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220930x10q.htm   iXBRL 10-Q 1979511
2 EX-31.1 tmb-20220930xex31d1.htm EX-31.1 13101
3 EX-31.2 tmb-20220930xex31d2.htm EX-31.2 12994
4 EX-32 tmb-20220930xex32.htm EX-32 9998
  Complete submission text file 0001410578-22-003441.txt   8955099

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20220930.xsd EX-101.SCH 83031
6 EX-101.CAL tmb-20220930_cal.xml EX-101.CAL 61797
7 EX-101.DEF tmb-20220930_def.xml EX-101.DEF 203488
8 EX-101.LAB tmb-20220930_lab.xml EX-101.LAB 565644
9 EX-101.PRE tmb-20220930_pre.xml EX-101.PRE 412917
86 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220930x10q_htm.xml XML 1745995
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39752 | Film No.: 221388027
SIC: 2834 Pharmaceutical Preparations